MTRF1LP2: A Potential Drug Target and Biomarker (G100130376)

Target Name: MTRF1LP2

NCBI ID: G100130376

MTRF1LP2

Other Name(s): mitochondrial translational release factor 1 like pseudogene 2 | Mitochondrial translational release factor 1 like pseudogene 2

MTRF1LP2: A Potential Drug Target and Biomarker

Mutations in the MTRF1 gene have been linked to a range of neurodegenerative diseases, including ALS, Parkinson's, and Huntington's diseases. The MTRF1 gene encodes a protein that is involved in the synthesis of a key component of the nervous system, called melatonin. MTRF1LP2, a variant of the MTRF1 gene, has been shown to be highly associated with the development of neurodegenerative diseases.

The MTRF1 gene encodes a protein that is composed of two subunits, MTRF1LP1 and MTRF1LP2. MTRF1LP1 is the protein that is synthesized from the MTRF1 gene, while MTRF1LP2 is a non-functional RNA molecule that is generated from the MTRF1 gene. MTRF1LP2 has been shown to play a crucial role in the regulation of melatonin synthesis and has been linked to the development of neurodegenerative diseases.

Studies have shown that MTRF1LP2 is highly expressed in the brains of individuals with neurodegenerative diseases. In addition, MTRF1LP2 has been shown to be involved in the regulation of melatonin synthesis, which is a key factor in the development of these diseases. MTRF1LP2 has been shown to interact with several other genes that are involved in the development of neurodegenerative diseases, including the TREBP gene, which encodes a key regulator of lipid metabolism.

In addition to its role in the development of neurodegenerative diseases, MTRF1LP2 has also been shown to have potential as a drug target. Studies have shown that MTRF1LP2 can be targeted by small molecules, which have the potential to treat neurodegenerative diseases. In addition, MTRF1LP2 has been shown to be involved in the regulation of cellular processes that are important for the development of neurodegenerative diseases, such as the regulation of axon growth and the regulation of neurotransmitter release.

In conclusion, MTRF1LP2 is a protein that has been shown to be involved in the development of neurodegenerative diseases. Studies have shown that MTRF1LP2 can be targeted by small molecules, which have the potential to treat these diseases. In addition, MTRF1LP2 has been shown to play a crucial role in the regulation of melatonin synthesis, which is a key factor in the development of these diseases. Further research is needed to fully understand the role of MTRF1LP2 in the development of neurodegenerative diseases and to develop effective treatments.

Protein Name: Mitochondrial Translational Release Factor 1 Like Pseudogene 2

The "MTRF1LP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTRF1LP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets